PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.97%
Revenue growth under 50% of ADI's 18.50%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
4.03%
Gross profit growth under 50% of ADI's 22.10%. Michael Burry would be concerned about a severe competitive disadvantage.
16.31%
EBIT growth below 50% of ADI's 37.67%. Michael Burry would suspect deeper competitive or cost structure issues.
12.45%
Operating income growth under 50% of ADI's 37.67%. Michael Burry would be concerned about deeper cost or sales issues.
207.84%
Net income growth above 1.5x ADI's 31.24%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
204.00%
EPS growth above 1.5x ADI's 29.63%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
200.00%
Diluted EPS growth above 1.5x ADI's 28.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
4.94%
Share count expansion well above ADI's 0.96%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.32%
Diluted share count expanding well above ADI's 2.10%. Michael Burry would fear significant dilution to existing owners' stakes.
-7.43%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
59.20%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
136.40%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
36.04%
10Y revenue/share CAGR under 50% of ADI's 232.56%. Michael Burry would suspect a lasting competitive disadvantage.
-23.23%
Negative 5Y CAGR while ADI stands at 238.76%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-0.63%
Negative 3Y CAGR while ADI stands at 93.55%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
277.93%
10Y OCF/share CAGR at 75-90% of ADI's 332.93%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
42.76%
Below 50% of ADI's 433.64%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-5.23%
Negative 3Y OCF/share CAGR while ADI stands at 93.87%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
8874.99%
Net income/share CAGR above 1.5x ADI's 1630.22% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
307.63%
5Y net income/share CAGR at 50-75% of ADI's 470.31%. Martin Whitman might see a shortfall in operational efficiency or brand power.
365.54%
3Y net income/share CAGR above 1.5x ADI's 190.51%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
292.02%
10Y equity/share CAGR 1.25-1.5x ADI's 245.37%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
211.37%
5Y equity/share CAGR at 50-75% of ADI's 331.94%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
153.92%
3Y equity/share CAGR above 1.5x ADI's 97.24%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
7.92%
Dividend/share CAGR of 7.92% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
29.26%
Dividend/share CAGR of 29.26% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-7.85%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.79%
AR growth well above ADI's 16.40%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.75%
Inventory growth well above ADI's 12.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
11.76%
Asset growth above 1.5x ADI's 7.22%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.81%
1.25-1.5x ADI's 5.90%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-1.82%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.25%
Our R&D shrinks while ADI invests at 9.28%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
3.09%
SG&A declining or stable vs. ADI's 10.19%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.